Got questions? Get in touch.
By Allianz Worldwide Care | December 12, 2013
International private medical insurer Allianz Worldwide Care has announced a number of new benefits and enhancements to its standard healthcare plans, following its recent annual product review. New and renewing group and individual clients will benefit from increased healthcare cover in a number of areas, including genetic testing, physiotherapy, rehabilitation, prescribed drugs, palliative care and long term care.
Susan Landers, Head of Marketing and Client Management said “Every year we monitor, review and improve on the level of cover available to our clients. Changes to cover are driven by feedback from our clients, so they often focus on very practical elements which support the way in which our members are actually using these plans. We also believe in the benefits of preventative care and in giving our clients access to the latest proven advances in medical treatment. This has been demonstrated by the introduction of cover for BRCA1 and BRCA2 genetic testing, the same test undertaken by Angelina Jolie to gauge the likelihood of developing breast cancer. All of this, combined with one of the lowest rates of premium increase in the market, provides our clients with comprehensive cover and competitive premiums.”
Details of the additional cover provided are listed below:
The changes will be reflected in Allianz Worldwide Care’s client Benefit Guides, which have recently been redesigned to create more concise and user-friendly documents.
The new Benefit Guides for employees and individuals are available to download from www.allianzworldwidecare.com
Tel: +44 (0) 207 932 1857
Mob: +44 (0) 781 436 5546
Tel: +44 (0) 207 932 1872
Mob: +44 (0) 794 679 4223